ChemicalBook

ANTI-HUMAN CD25 Product Description

ANTI-HUMAN CD25 Structure
CAS No.
Chemical Name:ANTI-HUMAN CD25
CBNumber:CB5492794
Molecular Formula:
Formula Weight:0
MOL File:Mol file
ANTI-HUMAN CD25 Synonyms:
ANTI-TAC (HUMAN)
ANTI-CD25
ANTI-CD25, HUMAN
ANTI-CD25/IL-2 RECEPTOR
ANTI-INTERLEUKIN-2 RECEPTOR
ANTI-INTERLEUKIN-2 RECEPTOR, MOUSE
ANTI-IL-2-R
ANTI-IL-2R-ALPHA (HUMAN)

ANTI-HUMAN CD25 Property

storage temp.  -20°C

Safety

ANTI-HUMAN CD25 Suppliers

Global( 19)Suppliers     
SupplierTelEmailCountryProdListAdvantage
Riedel-de Haen AG 800 558-9160 United States 6825 87
Cell Sciences, Inc. 888 769 1246 United States 1065 76
R & D Systems 612 379 2956info@rndsystems.comUnited States 2195 82
Vision BioSystems 800 753 7264sales.usa@vision-bio.comUnited States 542 74
BioSource International, Inc. 805 987-0086sales.desk@biosource.comUnited States 1011 63
BIODESIGN International/OEM Concepts 888 530 0140info@biodesign.comUnited States 2376 50
Cortex Biochem, Inc. 510 568 2228info@cortex-biochem.comUnited States 1557 77
Caltag Laboratories 800 874 4007caltag@caltag.comUnited States 1313 63
ANTI-HUMAN CD25 Related Search:
ANTI-TAC (HUMAN) ANTI-CD25 ANTI-CD25, HUMAN ANTI-CD25/IL-2 RECEPTOR ANTI-INTERLEUKIN-2 RECEPTOR ANTI-INTERLEUKIN-2 RECEPTOR, MOUSE ANTI-IL-2-R ANTI-IL-2R-ALPHA (HUMAN) ANTI-IL-2 RECEPTOR ALPHA ANTI-IL-2R MOUSE ANTI-HUMAN CD25, INTERLEUKIN-2-RECEPTOR ANTI-HUMAN CD25 ANTI-HUMAN IL-2 RECEPTOR A CHAIN/CD25, CLONE B-F2 ANTI-HUMAN IL-2 RECEPTOR A CHAIN/CD25, CLONE B-F2, FITC ANTI-HUMAN IL-2 RECEPTOR A CHAIN/CD25, CLONE B-F2, MONOCLONAL ANTIBODY ANTI-HUMAN IL-2 RECEPTOR A CHAIN/CD25, CLONE B-F2, MONOCLONAL ANTIBODY, FITC ANTI-HUMAN IL-2 RECEPTOR A CHAIN/CD25, CLONE B-G3 ANTI-HUMAN IL-2 RECEPTOR A CHAIN/CD25, CLONE B-G3, MONOCLONAL ANTIBODY ANTI-HUMAN IL2 RECEPTOR ALPHA ANTI-HUMAN IL-2 RECEPTOR (ALPHA-CHAIN) ANTI-HUMAN IL-2R ANTI-HUMAN IL-2 R-ALPHA EXTRACELLULAR DOMAIN ANTI-HUMAN IL-2 RECEPTOR ANTI-HUMAN INTERLEUKIN-2 RECEPTOR Anti-IL2RB (451-465) antibody produced in rabbit
Copyright 2017 © ChemicalBook. All rights reserved